Status:
COMPLETED
Nausea in Patients Receiving Hydromorphone vs Oxycodone After Total Hip Replacement Surgery
Lead Sponsor:
University Health Network, Toronto
Conditions:
Nausea
Eligibility:
All Genders
18-85 years
Phase:
PHASE4
Brief Summary
The study aims to compare the incidence of side effects caused by Oxycodone and Hydromorphone.
Detailed Description
Nausea and vomiting in the post-operative period is considered strongly undesirable by patients and has adverse effects on recovery from outpatient procedures, contributing significantly to delays in ...
Eligibility Criteria
Inclusion
- American Society of Anesthesiologists Physical Status Classification System 1-3
- Age 18-85 years
- Patients undergoing hip replacement surgery under spinal anesthesia
Exclusion
- patient refusal
- contraindication or refusal of spinal anesthesia
- inability to provide informed consent
- history of dementia
- intolerance or allergy to oxycodone or hydromorphone
- chronic opioid use or chronic pain disorder
- pregnancy
- history of drug addiction
- history of major psychiatric illness
Key Trial Info
Start Date :
August 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2016
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT02295124
Start Date
August 1 2012
End Date
January 1 2016
Last Update
November 27 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Toronto Western Hospital
Toronto, Ontario, Canada, M5T 2S8